Norihide Tei
Papers
1
Total Citations
4
H-Index
1
About
Norihide Tei is a clinician-researcher whose work sits at the critical intersection of urologic oncology and skeletal health. His primary research focus is the adverse effects of androgen deprivation therapy (ADT) in prostate cancer patients, with a specific emphasis on bone fragility and fracture risk. Tei’s major contribution is pioneering the use of quantitative computed tomography (QCT) to precisely measure volumetric bone mineral density, offering a far more accurate assessment of lumbar spine bone loss than traditional DXA scans. His landmark 2024 study, which employed a rigorous propensity-matched cohort design, demonstrated the significant impact of ADT on trabecular bone deterioration, providing actionable data for clinicians to mitigate fracture risk. With 4 citations already, this work is gaining traction as a critical reference for managing long-term ADT complications. Tei’s research is notable for its methodological precision and direct clinical applicability, helping to shift the standard of care toward more proactive bone health monitoring in prostate cancer survivors.
Research Focus
Key Achievements
Top Papers
- 1